Catalyst Wire Dossier Catalyst Wire Dossier

Nerventra

laquinimod · Teva Pharma GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nerventra, covering 2014-09-01 to 2014-09-01. Get the full timeline:

Most recent: EMA Refused: Nerventra (laquinimod) — Teva Pharma GmbH

See pricing